Inventor
COLLETTI STEVEN L
US37 patents
⚠️ This page may combine multiple inventors who share the name “COLLETTI STEVEN L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIRNA THERAPEUTICS INC
16 patentsUS9604908B2Mar 28, 2017
Diether based biodegradable cationic lipids for siRNA delivery
SIRNA THERAPEUTICS INC39 citations94
US9458090B2Oct 4, 2016
Low molecular weight cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC9 citations84
US9402816B2Aug 2, 2016
Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC10 citations84
US9655976B2May 23, 2017
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC6 citations82
US9643916B2May 9, 2017
Low molecular weight cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC5 citations82
US9062021B2Jun 23, 2015
Low molecular weight cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC6 citations82
US9446132B2Sep 20, 2016
Diether based biodegradable cationic lipids for siRNA delivery
SIRNA THERAPEUTICS INC4 citations73
US11117917B2Sep 14, 2021
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC2 citations71
US10221205B2Mar 5, 2019
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC3 citations71
US9315437B2Apr 19, 2016
Low molecular weight cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC3 citations71
US12304925B2May 20, 2025
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC0 citations60
US10307378B2Jun 4, 2019
Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC0 citations52
US9981907B2May 29, 2018
Low molecular weight cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC0 citations52
US9861589B2Jan 9, 2018
Diester and triester based low molecular weight, biodegradeable cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC0 citations52
US9044512B2Jun 2, 2015
Amino alcohol cationic lipids for oligonucleotide delivery
SIRNA THERAPEUTICS INC1 citations51
US9840531B2Dec 12, 2017
Tetragalnac and peptide containing conjugates and methods for delivery of oligonucleotides
SIRNA THERAPEUTICS INC0 citations50
MERCK SHARP & DOHME
7 patentsUS10532068B2Jan 14, 2020
Dual molecular delivery of oligonucleotides and peptide containing conjugates
MERCK SHARP & DOHME3 citations71
US10010562B2Jul 3, 2018
Dual molecular delivery of oligonucleotides and peptide containing conjugates
MERCK SHARP & DOHME3 citations71
US9932311B2Apr 3, 2018
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME4 citations71
US10968193B2Apr 6, 2021
Antidiabetic bicyclic compounds
MERCK SHARP & DOHME1 citations62
US7662846B2Feb 16, 2010
Selective spirocyclic glucocorticoid receptor modulators
MERCK SHARP & DOHME0 citations41
US10519115B2Dec 31, 2019
Antidiabetic tricyclic compounds
MERCK SHARP & DOHME0 citations39
US10239957B2Mar 26, 2019
Peptide containing conjugates for dual molecular delivery of oligonucleotides
MERCK SHARP & DOHME0 citations39
COLLETTI STEVEN L
4 patentsUS9029590B2May 12, 2015
Low molecular weight cationic lipids for oligonucleotide delivery
COLLETTI STEVEN L43 citations97
US9670487B2Jun 6, 2017
Cationic lipids for oligonucleotide delivery
COLLETTI STEVEN L4 citations65
US8455520B2Jun 4, 2013
Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
COLLETTI STEVEN L1 citations51
US11225471B2Jan 18, 2022
Antidiabetic bicyclic compounds
COLLETTI STEVEN L0 citations50
MERCK & CO INC
4 patentsUS6399786B1Jun 4, 2002
Nonacyclic nodulisporic acid derivatives
MERCK & CO INC63 citations96
US7196095B2Mar 27, 2007
(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
MERCK & CO INC8 citations71
US7411073B2Aug 12, 2008
Selective non-steroidal glucocorticoid receptor modulators
MERCK & CO INC5 citations62
US6586452B1Jul 1, 2003
C1 to C4 side chain modified nodulisporic acid analogs
MERCK & CO INC7 citations61